Sandoz has issued a nationwide recall of two lots of cefazolin for injection due to a labeling error. The mislabeled vials were sent to wholesalers for nationwide distribution.
The error was found after a complaint showed that the cefazolin vials were packaged and labeled as penicillin G potassium for injection, according to a July 15 news release from the FDA.
Although both drugs are antibiotics, they treat different infections and have different dosing regimens. Mistaken use of the drugs could lead to serious health risks, including ineffective treatment, allergic reactions and other complications.
The FDA urges healthcare providers to stop using the recalled products immediately. No injuries have been reported so far, but one instance of the wrong drug being administered has been confirmed.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.